...
首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >New Derivative Spectrophotometric Methods for the Determination of Epalrestat – An Anti Diabetic Drugby Sharath Chandra. Seelam, Dhanalakshmi.K, Nagarjuna reddy, India.
【24h】

New Derivative Spectrophotometric Methods for the Determination of Epalrestat – An Anti Diabetic Drugby Sharath Chandra. Seelam, Dhanalakshmi.K, Nagarjuna reddy, India.

机译:用于测定依帕司他(Epalrestat)的新的衍生分光光度法-Sharath Chandra研发的抗糖尿病药物。印度Nagarjuna Reddy的Dhanalakshmi.K Seelam。

获取原文

摘要

Quality by Design (QbD) refers to a holistic approach towards drug development. Quality by design is a vital part of the modern approach to pharmaceutical quality. There is much confusion among pharmaceutical scientists in generic drug industry about the appropriate element and terminology of quality by design. The purpose of this paper is to discuss the pharmaceutical Quality by Design (QbD) and illustrate how it can be used to ensure pharmaceutical quality. The QbD is a systemic approach to pharmaceutical development. It means designing and developing formulations and manufacturing processes to ensure predefined product quality. Some of the QbD elements include: Defining Quality target product profile, Identifying critical quality attributes, link the drug excipients attributes, establishing design space, control strategy, and product life cycle management. Using QbD, pharmaceutical quality is assured by understanding and controlling formulation and manufacturing variables. A new approach to drug development could increase efficiencies, provide regulatory support and flexibility, and offer important business benefits throughout the product’s life cycle. This article explores the processes used in developing a market formulation and required supportive data, particularly in light of the industry’s current movement toward submissions based on QbD. The work also facilitates the adoption and implementation of QbD. principles in the development of pharmaceutical industries. Successful implementation of QbD concepts requires cooperation across a multitude of company teams, from R&D to manufacturing to quality control and regulatory affairs. This is necessary to ensure that QbD concepts are incorporated not only when the first activities are initiated around a product’s design but also during the design of the process used to make the product and other activities associated with a product’s life cycle. The application of the concept of quality by design (QbD) presented in this paper aligns with the principles of ICH Q8, Q9 and Q10 guidelines.
机译:设计质量(QbD)是指开发药物的整体方法。设计质量是现代药物质量方法的重要组成部分。通用药物行业中的药物科学家对设计中适当的要素和质量术语存在很多困惑。本文的目的是讨论药品的设计质量(QbD),并说明如何将其用于确保药品质量。 QbD是药物开发的系统方法。这意味着设计和开发配方和制造工艺以确保预定义的产品质量。 QbD要素包括:定义质量目标产品概况,识别关键质量属性,链接药物赋形剂属性,建立设计空间,控制策略和产品生命周期管理。使用QbD,可以通过了解和控制配方和制造变量来确保药品质量。一种新的药物开发方法可以提高效率,提供监管支持和灵活性,并在产品的整个生命周期中提供重要的业务收益。本文探讨了开发市场公式和所需支持数据的过程,尤其是考虑到该行业当前正在朝着基于QbD提交的方向发展。这项工作还促进了QbD的采用和实施。制药工业发展中的原则。成功实施QbD概念需要从研发到制造到质量控制和法规事务的众多公司团队之间的合作。有必要确保不仅在围绕产品设计启动首个活动时,而且在用于制造产品的流程设计过程中以及与产品生命周期相关的其他活动中都纳入QbD概念。本文提出的质量设计概念(QbD)的应用符合ICH Q8,Q9和Q10准则的原则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号